PLA-HA/Fe3O4 magnetic nanoparticles loaded with curcumin: physicochemical characterization and toxicity evaluation in HCT116 colorectal cancer cells

Springer Science and Business Media LLC - Tập 6 Số 4
Shima Bourang, Sina Asadian, Mehran Noruzpour, Atefeh Mansuryar, Solmaz Azizi, Hossein Ali Ebrahimi, Vahid Amani Hooshyar

Tóm tắt

AbstractColorectal cancer (CRC) is the third most common, harmful, and universal cancer and the second lethal type. This paper discusses the therapeutic potential of curcumin, a significant curcuminoid found in the substructure of plant Curcuma longa (turmeric), against CRC. Curcumin has the ability to disrupt a variety of cellular signaling pathways and has been validated in several preclinical and clinical studies, but suffers from low solubility and bioavailability. Despite the widespread use of curcumin (CU) against colorectal cancer, it presents limitations, such as low solubility and bioavailability. Due to these drawbacks, researchers focused on new methods to carry CU into cells to overcome the limits of treatments with CU. One of the leading solutions is bioanalytical methods, which are based on using CU in combination with nanoparticles, especially magnetic nanoparticles, which cause the targeted transfer of the drug to cancer cells. To address these issues, PLA-HA/Fe3O4 magnetic nanoparticles were synthesized and loaded with curcumin. The average size and zeta potential of the nanoparticles and the magnetic properties were measured. The drug encapsulation efficiency and cumulative release of curcumin from the nanoparticles under acidic and neutral pH (4.8, 6, and 7.4) values were evaluated, as well as the cytotoxic effect of the nanoparticles on HCT116 colorectal cancer cells. According to the results of DLS and TEM analysis, PLA/Fe3O4/curcumin nanoparticles had a spherical structure with an average size of 208 Å ± 12.8 nm and a Zeta potential of − 18 (mV). The drug encapsulation efficiency in PLA-HA/Fe3O4 nanoparticles was 24.8 ± 4.6 percent. The drug's release rate was influenced by acidic and neutral pH levels. After 14 days, the highest release rate was 98% at pH 4.8 and over 94% at pH 6 (typical of cancer cells). In contrast, the drug's release at pH 7.4 (typical of healthy cells) after 14 days was only 59%. The results demonstrated that nanoparticles have a high degree of biocompatibility and the ability to carry Curcumin medications. HCT116 cells with 200 μg/ml PLA-HA/Fe3O4/Curcumin nanoparticles have 58.63 ± 3.7% percent cell viability. Ultimately, PLA-HA, Fe3O4, and Curcumin's physicochemical characteristics and impact on cell viability render them valuable instruments for precisely delivering drugs to colorectal cancer cells. The PLA-HA/Fe3O4–curcumin nanoparticles demonstrated a well-targeted drug delivery system for upcoming colorectal cancer treatments, as evidenced by their strong cytotoxic effects on colorectal cancer cells and negligible toxicity towards non-cancerous cells. Graphical abstract

Từ khóa


Tài liệu tham khảo

Dekker E, Tanis PJ, Vleugels J, Kasi PM, Wallace M. Pure-AMC. Lancet. 2019;394:1467–80.

Bando H, Ohtsu A, Yoshino T. Therapeutic landscape and future direction of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol. 2023;20(5):306–22. https://doi.org/10.1038/s41575-022-00736-1.

Fanotto V, Salani F, Vivaldi C, Scartozzi M, Ribero D, Puzzoni M, et al. Primary tumor resection for metastatic colorectal, gastric and pancreatic cancer patients: in search of scientific evidence to inform clinical practice. Cancers. 2023;15(3):900. https://doi.org/10.3390/cancers15030900.

Heemskerk-Gerritsen BA, Rookus MA, Aalfs CM, Ausems MG, Collée JM, Jansen L, et al. Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis. Int J Cancer. 2015;136(3):668–77. https://doi.org/10.1016/j.breastdis.2015.07.032.

Kalyan A, Kircher S, Shah H, Mulcahy M, Benson A. Updates on immunotherapy for colorectal cancer. J Gastrointest Oncol. 2018;9(1):160. https://doi.org/10.21037/jgo.2018.01.17.

Kircher SM, Nimeiri HS, Benson AB III. Targeting angiogenesis in colorectal cancer: tyrosine kinase inhibitors. Cancer J. 2016;22(3):182–9. https://doi.org/10.1097/ppo.0000000000000192.

Dasineh S, Akbarian M, Ebrahimi HA, Behbudi G. Tacrolimus-loaded chitosan-coated nanostructured lipid carriers: preparation, optimization and physicochemical characterization. Appl Nanosci. 2021;11:1169–81. https://doi.org/10.1007/s13204-021-01744-4.

Ebrahimi HA, Javadzadeh Y, Hamidi M, BarzegarJalali M. Development and characterization of a novel lipohydrogel nanocarrier: repaglinide as a lipophilic model drug. J Pharm Pharmacol. 2016;68(4):450–8. https://doi.org/10.1111/jphp.12537.

Fasili Z, Mehri F, Ebrahimi HA, Jamali Z, Mohammad Khanlou E, Kahrizi F, Salimi A. Applying nanoparticles in the treatment of viral infections and toxicological considerations. Pharm Biomed Res. 2019;5(4):1–20. https://doi.org/10.18502/pbr.v5i4.2392.

Willenbacher E, Khan SZ, Mujica SCA, Trapani D, Hussain S, Wolf D, et al. Curcumin: new insights into an ancient ingredient against cancer. Int J Mol Sci. 2019;20(8):1808. https://doi.org/10.3390/ijms20081808.

Bachmeier BE, Killian PH, Melchart D. The role of curcumin in prevention and management of metastatic disease. Int J Mol Sci. 2018;19(6):1716. https://doi.org/10.3390/ijms19061716.

Gonçalves PB, Romeiro NC. Multi-target natural products as alternatives against oxidative stress in chronic obstructive pulmonary disease (COPD). Eur J Med Chem. 2019;163:911–31. https://doi.org/10.1016/j.ejmech.2018.12.020.

Khan H, Ullah H, Nabavi SM. Mechanistic insights of hepatoprotective effects of curcumin: therapeutic updates and future prospects. Food Chem Toxicol. 2019;124:182–91. https://doi.org/10.1016/j.fct.2018.12.002.

Chen C-Y, Kao C-L, Liu C-M. The cancer prevention, anti-inflammatory and anti-oxidation of bioactive phytochemicals targeting the TLR4 signaling pathway. Int J Mol Sci. 2018;19(9):2729. https://doi.org/10.3390/ijms19092729.

Jankun J, Wyganowska-Świątkowska M, Dettlaff K, Jelińska A, Surdacka A, Wątróbska-Świetlikowska D, Skrzypczak-Jankun E. Determining whether curcumin degradation/condensation is actually bioactivation. Int J Mol Med. 2016;37(5):1151–8. https://doi.org/10.3892/ijmm.2016.2524.

Mirzaei H, Masoudifar A, Sahebkar A, Zare N, Sadri Nahand J, Rashidi B, et al. MicroRNA: a novel target of curcumin in cancer therapy. J Cell Physiol. 2018;233(4):3004–15. https://doi.org/10.1002/jcp.26055.

Bahrami A, Amerizadeh F, ShahidSales S, Khazaei M, Ghayour-Mobarhan M, Sadeghnia HR, et al. Therapeutic potential of targeting Wnt/β-catenin pathway in treatment of colorectal cancer: rational and progress. J Cell Biochem. 2017;118(8):1979–83. https://doi.org/10.1002/jcb.25903.

Allegra A, Innao V, Russo S, Gerace D, Alonci A, Musolino C. Anticancer activity of curcumin and its analogues: preclinical and clinical studies. Cancer Investig. 2017;35(1):1–22. https://doi.org/10.1080/07357907.2016.1247166.

Salehi B, Stojanović-Radić Z, Matejić J, Sharifi-Rad M, Kumar NVA, Martins N, Sharifi-Rad J. The therapeutic potential of curcumin: a review of clinical trials. Eur J Med Chem. 2019;163:527–45. https://doi.org/10.1016/j.ejmech.2018.12.016.

Mundekkad D, Cho WC. Applications of curcumin and its nanoforms in the treatment of cancer. Pharmaceutics. 2023;15(9):2223. https://doi.org/10.3390/pharmaceutics15092223.

Victorelli FD, Manni LS, Biffi S, Bortot B, Buzzá HH, Lutz-Bueno V, et al. Potential of curcumin-loaded cubosomes for topical treatment of cervical cancer. J Colloid Interface Sci. 2022;620:419–30. https://doi.org/10.1016/j.jcis.2022.04.031.

Tabanelli R, Brogi S, Calderone V. Improving curcumin bioavailability: current strategies and future perspectives. Pharmaceutics. 2021;13(10):1715. https://doi.org/10.3390/pharmaceutics13101715.

Zoi V, Galani V, Lianos GD, Voulgaris S, Kyritsis AP, Alexiou GA. The role of curcumin in cancer treatment. Biomedicines. 2021;9(9):1086. https://doi.org/10.5772/27874.

Pricci M, Girardi B, Giorgio F, Losurdo G, Ierardi E, Di Leo A. Curcumin and colorectal cancer: from basic to clinical evidences. Int J Mol Sci. 2020;21(7):2364. https://doi.org/10.3390/ijms21072364.

He Y-c, He L, Khoshaba R, Lu F-g, Cai C, Zhou F-l, et al. Curcumin nicotinate selectively induces cancer cell apoptosis and cycle arrest through a P53-mediated mechanism. Molecules. 2019;24(22):4179. https://doi.org/10.3390/molecules24224179.

Karthikeyan A, Senthil N, Min T. Nanocurcumin: a promising candidate for therapeutic applications. Front Pharmacol. 2020;11: 529594. https://doi.org/10.3389/fphar.2020.00487.

Weng W, Goel A. Curcumin and colorectal cancer: an update and current perspective on this natural medicine. Semin Cancer Biol. 2022;80:73–86. https://doi.org/10.1016/j.semcancer.2020.02.011.

Yusuf A, Almotairy ARZ, Henidi H, Alshehri OY, Aldughaim MS. Nanoparticles as drug delivery systems: a review of the implication of nanoparticles’ physicochemical properties on responses in biological systems. Polymers. 2023;15(7):1596. https://doi.org/10.3390/polym15071596.

Sukumaran S, Neelakandan M, Shaji N, Prasad P, Yadunath V. Magnetic nanoparticles: synthesis and potential biological applications. JSM Nanotechnol Nanomed. 2018;6(2):1068.

Chen Y-T, Kolhatkar AG, Zenasni O, Xu S, Lee TR. Biosensing using magnetic particle detection techniques. Sensors. 2017;17(10):2300. https://doi.org/10.3390/s17102300.

Ganapathe LS, Mohamed MA, Mohamad Yunus R, Berhanuddin DD. Magnetite (Fe3O4) nanoparticles in biomedical application: from synthesis to surface functionalisation. Magnetochemistry. 2020;6(4):68. https://doi.org/10.3390/magnetochemistry6040068.

Chen Y, Ding X, Zhang Y, Natalia A, Sun X, Wang Z, Shao H. Design and synthesis of magnetic nanoparticles for biomedical diagnostics. Quant Imaging Med Surg. 2018;8(9):957. https://doi.org/10.21037/qims.2018.10.07.

Noqta OA, Aziz AA, Usman IA, Bououdina M. Recent advances in iron oxide nanoparticles (IONPs): synthesis and surface modification for biomedical applications. J Supercond Novel Magn. 2019;32:779–95. https://doi.org/10.1007/s10948-018-4939-6.

Amani A, Alizadeh MR, Yaghoubi H, Ebrahimi HA. Design and fabrication of novel multi-targeted magnetic nanoparticles for gene delivery to breast cancer cells. J Drug Deliv Sci Technol. 2021;61: 102151. https://doi.org/10.1016/j.jddst.2020.102151.

Nasab SH, Amani A, Ebrahimi HA, Hamidi AA. Design and preparation of a new multi-targeted drug delivery system using multifunctional nanoparticles for co-delivery of siRNA and paclitaxel. J Pharm Anal. 2021;11(2):163–73. https://doi.org/10.22541/au.157541388.85913601.

Drumright RE, Gruber PR, Henton DE. Polylactic acid technology. Adv Mater. 2000;12(23):1841–6.

Nurazzi N, Harussani M, Zulaikha NS, Norhana A, Syakir MI, Norli A. Composites based on conductive polymer with carbon nanotubes in DMMP gas sensors—an overview. Polimery. 2021;66(2):85–97. https://doi.org/10.14314/polimery.2021.2.1.

Ali SSS, Razman MR, Awang A. The nexus of population, GDP growth, electricity generation, electricity consumption and carbon emissions output in Malaysia. Int J Energy Econ Policy. 2020;10(3):84–9. https://doi.org/10.32479/ijeep.8987.

Feghali E, Tauk L, Ortiz P, Vanbroekhoven K, Eevers W. Catalytic chemical recycling of biodegradable polyesters. Polym Degrad Stab. 2020;179: 109241. https://doi.org/10.1016/j.polymdegradstab.2020.109241.

Amani A, Dustparast M, Noruzpour M, Zakaria RA, Ebrahimi HA. Design and invitro characterization of green synthesized magnetic nanoparticles conjugated with multitargeted poly lactic acid copolymers for co-delivery of siRNA and paclitaxel. Eur J Pharm Sci. 2021;167: 106007. https://doi.org/10.1016/j.ejps.2021.106007.

Maga D, Hiebel M, Aryan V. A comparative life cycle assessment of meat trays made of various packaging materials. Sustainability. 2019;11(19):5324. https://doi.org/10.3390/su11195324.

Chitaka TY, Russo V, von Blottnitz H. In pursuit of environmentally friendly straws: a comparative life cycle assessment of five straw material options in South Africa. Int J Life Cycle Assess. 2020;25:1818–32. https://doi.org/10.1007/s11367-020-01786-w.

Hajleh A, Al-Samydai A, Al-Dujaili EA. Nano, micro particulate and cosmetic delivery systems of polylactic acid: a mini review. J Cosmet Dermatol. 2020;19(11):2805–11. https://doi.org/10.1111/jocd.13696.

Kesharwani P, Chadar R, Sheikh A. CD44-targeted nanocarrier for cancer therapy. Front Pharmacol. 2022;12: 800481. https://doi.org/10.3389/fphar.2021.800481.

Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 2003;4(1):33–45. https://doi.org/10.1038/nrm1004.

Rao NV, Yoon HY, Han HS, Ko H, Son S, Lee M, et al. Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment. Expert Opin Drug Deliv. 2016;13(2):239–52. https://doi.org/10.1517/17425247.2016.1112374.

Warthen J Jr, Stokes J, Jacobson M, Kozempel M. Estimation of azadirachtin content in neem extracts and formulations. J Liq Chromatogr. 1984;7(3):591–8. https://doi.org/10.1080/01483918408073988.

Shete P, Patil R, Tiwale B, Pawar S. Water dispersible oleic acid-coated Fe3O4 nanoparticles for biomedical applications. J Magn Magn Mater. 2015;377:406–10. https://doi.org/10.1016/j.jmmm.2014.10.137.

Bourang S, Noruzpour M, Azizi S, Yaghoubi H, Ebrahimi HA. Synthesis and in vitro characterization of PCL-PEG-HA/FeCo magnetic nanoparticles encapsulating curcumin and 5-FU. Nanomed J. 2024. https://doi.org/10.22038/nmj.2024.76219.1857.

Trang NTT, Chinh NT, Giang NV, Thanh DTM, Lam TD, Thu LV, et al. Hydrolysis of green nanocomposites of poly (lactic acid)(PLA), chitosan (CS) and polyethylene glycol (PEG) in acid solution. Green Process Synthesis. 2016;5(5):443–9. https://doi.org/10.1515/nano.0015.2016-0060.

Guo S, Liang Y, Liu L, Yin M, Wang A, Sun K, et al. Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics. J Nanobiotechnol. 2021;19:1–21. https://doi.org/10.1186/s12951-021-00770-2.

Chehelgerdi M, Chehelgerdi M, Allela OQB, Pecho RDC, Jayasankar N, Rao DP, et al. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. 2023;22(1):169. https://doi.org/10.1186/s12943-023-01865-0.

Shieh M-J, Peng C-L, Lou P-J, Chiu C-H, Tsai T-Y, Hsu C-Y, et al. Non-toxic phototriggered gene transfection by PAMAM-porphyrin conjugates. J Control Release. 2008;129(3):200–6. https://doi.org/10.1016/j.jconrel.2008.03.024.

Dang Y, Guan J. Nanoparticle-based drug delivery systems for cancer therapy. Smart Mater Med. 2020;1:10–9.

Alam N, Koul M, Mintoo MJ, Khare V, Gupta R, Rawat N, et al. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor. Biomed Pharmacother. 2017;95:856–64. https://doi.org/10.1016/j.biopha.2017.08.108.

Bami MS, Estabragh MAR, Khazaeli P, Ohadi M, Dehghannoudeh G. pH-responsive drug delivery systems as intelligent carriers for targeted drug therapy: brief history, properties, synthesis, mechanism and application. J Drug Deliv Sci Technol. 2022;70: 102987. https://doi.org/10.1016/j.jddst.2021.102987.

Mahdian M, Asrari SA, Ahmadi M, Madrakian T, Jalal NR, Afkhami A, et al. Dual stimuli-responsive gelatin-based hydrogel for pH and temperature-sensitive delivery of curcumin anticancer drug. J Drug Deliv Sci Technol. 2023;84: 104537. https://doi.org/10.1016/j.jddst.2023.104537.

Nabavinia M, Beltran-Huarac J. Recent progress in iron oxide nanoparticles as therapeutic magnetic agents for cancer treatment and tissue engineering. ACS Appl Bio Mater. 2020;3(12):8172–87. https://doi.org/10.1021/acsabm.0c00947.

Monteserín M, Larumbe S, Martínez AV, Burgui S, Francisco Martín L. Recent advances in the development of magnetic nanoparticles for biomedical applications. J Nanosci Nanotechnol. 2021;21(5):2705–41.

Yu Q, Sun J, Zhu X, Qiu L, Xu M, Liu S, et al. Mesoporous titanium dioxide nanocarrier with magnetic-targeting and high loading efficiency for dual-modal imaging and photodynamic therapy. J Mater Chem B. 2017;5(30):6081–96. https://doi.org/10.1039/c7tb01035d.

Amani A, Begdelo JM, Yaghoubi H, Motallebinia S. Multifunctional magnetic nanoparticles for controlled release of anticancer drug, breast cancer cell targeting, MRI/fluorescence imaging, and anticancer drug delivery. J Drug Deliv Sci Technol. 2019;49:534–46. https://doi.org/10.1016/j.jddst.2018.12.034.

Bhatnagar P, Kumari M, Pahuja R, Pant A, Shukla Y, Kumar P, Gupta K. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors. Drug Deliv Transl Res. 2018;8:565–79. https://doi.org/10.1007/s13346-018-0485-9.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 6 Số 4

Thông tin tác giả